Outcomes of childhood TB in countries with a universal BCG vaccination policy

J V Dias1, L Varandas2, L Gonçalves3

  • 1Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Department of Paediatrics, Hospital Beatriz Ângelo, Loures.

Insights

Childhood tuberculosis (TB) outcomes remain concerning, with a 19.5% unfavorable outcome rate and a 6.1% case-fatality ratio. Targeted health policies are crucial to improve treatment results for pediatric TB patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) significantly impacts childhood morbidity and mortality.
  • Underdiagnosis and limited data obscure the true burden of pediatric TB.
  • Existing data underestimates the impact of childhood TB.

Purpose of the Study:

  • To systematically review and characterize treatment outcomes in childhood tuberculosis.
  • To provide updated epidemiological data on pediatric TB outcomes.
  • To inform public health strategies for combating childhood TB.

Main Methods:

  • Systematic review of studies published between 2000 and 2020.
  • Inclusion of studies on children (0-14 years) in countries with universal BCG vaccination.
  • Random effects meta-analysis to synthesize treatment outcome data.

Main Results:

  • 35 articles were included from 1,806 references.
  • Overall unfavorable outcome proportion was 19.5%; pooled case-fatality ratio was 6.1%.
  • Case-fatality was higher in younger children (0-4 years: 6.6%) and TB/HIV co-infected children (15.1%).

Conclusions:

  • Childhood TB treatment outcomes are still a significant global health concern.
  • Intensified efforts and targeted health policies are needed for vulnerable pediatric populations.
  • Addressing data gaps is essential to effectively manage and reduce the global TB burden in children.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
322
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Vaccinations01:51

Vaccinations

Overview
44.4K